Gauss Surgical, a Los Altos, California-based healthcare technology company, announced that it raised $20 million in Series C funding to speed up the adoption of its Triton platform and develop new solutions.
The company’s Triton platform uses digital imaging and artificial intelligence (AI) to monitor a patient’s blood loss in real time. Users access it with an iPad from within the operating room.
The funding came from Northwell Health, SoftBank Ventures Korea, the LS Polaris Innovation Fund and other health systems based in the United States.
“The practical application of AI in hospitals will be a major growth driver in the medical technology industry, especially in addressing high-cost, high-impact unmet clinical needs,” Siddarth Satish, founder and CEO of Gauss, said in a prepared statement. “We are pleased to be strategically aligned with investors who bring significant operational experience both in AI-enabled services and in healthcare as we scale our platform.”
“As a leader in the AI-driven healthcare technology field, Gauss is profoundly altering the delivery model for medical devices and services in hospitals,” J.P. Lee, CEO and managing director of SoftBank Ventures Korea, said in the same statement. “We are excited to back the company and its founder's vision to fundamentally transform the way operating and delivery rooms work.”
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.